Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Psychological drivers in doping: the life-cycle model of performance enhancement.

Petróczi A, Aidman E.

Subst Abuse Treat Prev Policy. 2008 Mar 10;3:7. doi: 10.1186/1747-597X-3-7.

2.

Personal and psychosocial predictors of doping use in physical activity settings: a meta-analysis.

Ntoumanis N, Ng JY, Barkoukis V, Backhouse S.

Sports Med. 2014 Nov;44(11):1603-24. doi: 10.1007/s40279-014-0240-4. Review.

PMID:
25138312
3.

Prevalence of doping use in elite sports: a review of numbers and methods.

de Hon O, Kuipers H, van Bottenburg M.

Sports Med. 2015 Jan;45(1):57-69. doi: 10.1007/s40279-014-0247-x. Review.

PMID:
25169441
4.

Should performance-enhancing drugs in sport be legalized under medical supervision?

Wiesing U.

Sports Med. 2011 Feb 1;41(2):167-76. doi: 10.2165/11537530-000000000-00000. Review.

PMID:
21244107
5.

Doping in competition or doping in sport?

Lippi G, Franchini M, Guidi GC.

Br Med Bull. 2008;86:95-107. doi: 10.1093/bmb/ldn014. Epub 2008 Apr 1. Review.

PMID:
18385161
6.

Human genetic variation: new challenges and opportunities for doping control.

Schneider AJ, Fedoruk MN, Rupert JL.

J Sports Sci. 2012;30(11):1117-29. doi: 10.1080/02640414.2012.692480. Epub 2012 Jun 11. Review.

PMID:
22681541
7.

Position stand on androgen and human growth hormone use.

Hoffman JR, Kraemer WJ, Bhasin S, Storer T, Ratamess NA, Haff GG, Willoughby DS, Rogol AD.

J Strength Cond Res. 2009 Aug;23(5 Suppl):S1-S59. doi: 10.1519/JSC.0b013e31819df2e6. Review. Erratum in: J Strength Cond Res. 2010 Feb;24(2):585.

PMID:
19620932
8.

[Medication, athletes and doping regulations].

Hartgens F.

Ned Tijdschr Geneeskd. 2008 Aug 16;152(33):1844-8. Review. Dutch.

PMID:
18783164
9.

Doping through supplement use: a review of the available empirical data.

Outram S, Stewart B.

Int J Sport Nutr Exerc Metab. 2015 Feb;25(1):54-9. doi: 10.1123/ijsnem.2013-0174. Review.

PMID:
25722470
10.

American Medical Society for Sports Medicine position statement: concussion in sport.

Harmon KG, Drezner JA, Gammons M, Guskiewicz KM, Halstead M, Herring SA, Kutcher JS, Pana A, Putukian M, Roberts WO.

Br J Sports Med. 2013 Jan;47(1):15-26. doi: 10.1136/bjsports-2012-091941. Review. Erratum in: Br J Sports Med. 2013 Feb;47(3):184.

PMID:
23243113
11.

Treating the elite athlete: anti-doping information for the health professional.

Tandon S, Bowers LD, Fedoruk MN.

Mo Med. 2015 Mar-Apr;112(2):122-8. Review.

PMID:
25958657
12.

Gene doping: an overview and current implications for athletes.

van der Gronde T, de Hon O, Haisma HJ, Pieters T.

Br J Sports Med. 2013 Jul;47(11):670-8. doi: 10.1136/bjsports-2012-091288. Epub 2013 Jan 15. Review.

PMID:
23322893
13.

Drug misuse in sport: a New Zealand perspective.

Curtis A, Gerrard D, Burt P, Osborne H.

N Z Med J. 2015 Dec 4;128(1426):62-8. Review.

PMID:
26913908
14.

Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.

Gosetti F, Mazzucco E, Gennaro MC, Marengo E.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 May 15;927:22-36. doi: 10.1016/j.jchromb.2012.12.003. Epub 2012 Dec 20. Review.

PMID:
23317577
15.

Predictors of doping intentions, susceptibility, and behaviour of elite athletes: a meta-analytic review.

Blank C, Kopp M, Niedermeier M, Schnitzer M, Schobersberger W.

Springerplus. 2016 Aug 11;5(1):1333. doi: 10.1186/s40064-016-3000-0. eCollection 2016. Review.

16.

Narrowing the gap between the number of athletes who dope and the number of athletes who are caught: scientific advances that increase the efficacy of antidoping tests.

Botrè F, de la Torre X, Donati F, Mazzarino M.

Br J Sports Med. 2014 May;48(10):833-6. doi: 10.1136/bjsports-2014-093563. Epub 2014 Mar 25. Review.

PMID:
24668049
17.

Supplements and inadvertent doping - how big is the risk to athletes.

Judkins C, Prock P.

Med Sport Sci. 2012;59:143-52. doi: 10.1159/000341970. Epub 2012 Oct 15. Review.

PMID:
23075565
18.

Doping and musculoskeletal system: short-term and long-lasting effects of doping agents.

Nikolopoulos DD, Spiliopoulou C, Theocharis SE.

Fundam Clin Pharmacol. 2011 Oct;25(5):535-63. doi: 10.1111/j.1472-8206.2010.00881.x. Epub 2010 Oct 6. Review.

PMID:
21039821
19.

Gene doping: possibilities and practicalities.

Wells DJ.

Med Sport Sci. 2009;54:166-75. doi: 10.1159/000235703. Epub 2009 Aug 17. Review.

PMID:
19696514
20.

[Doping in high-level athletes].

Chalchat B.

Ann Pharm Fr. 2002 Sep;60(5):303-9. Review. French.

PMID:
12378138

Supplemental Content

Support Center